Selected Publications

Butters A, Arnott C, Sweeting J, Claggett B, Cuomo A, Abrams D, Ashley EA, Day SM, Helms AS, Lampert R, Lin K, Michels M, Miller EM, Olivotto I, Owens A, Parikh VN, Pereira AC, Rossano JW, Ryan TD, Saberi S, Stendahl JC, Ware JS, Atherton J, Semsarian C, Lakdawala NK, Ho CY, Ingels J: Sex-specific clinical and genetic factors associated with adverse outcomes in hypertrophic cardiomyopathy. Circulation: Genomic and Precision Medicine. In Press, 2025

Griffiths ER, Profsky MP, Mokshagundam D, Boucek K, Amdani S, Davies RR, Monge MC, Morales DL, Rossano JW, Jacobs JP, Kirklin JK, Koehl D, Cantor R, Peng DM; Pedimacs Investigators: Eighth annual Society of Thoracic Surgeons Pedimacs report. The Annals of Thoracic Surgery 119: 513-522, 2025.

Topriceanu CC, Vissing CR, Axelsson Raja A, Day SM, Russell MW, Zahka K, Pereira AC, Colan SD, Murphy AM, Canter C, Bach RG, Wheeler MT, Rossano JW, Owens AT, Mestroni L, Taylor MRG, Moon JC, Captur G, Patel AR, Wilmot I, Soslow JH, Becker JR, Seidman CE, Lakdawala NK, Bundgaard H, Tahir UA, Ho CY. : Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial. Circulation: Heart Failure 2025 Notes: In Press.

Gathers CL, Rossano JW, Griffis H, McNally B, Al-Araji R, Berg RA, Chung S, Nadkarni V, Tobin JM, Naim MY: Sociodemographic disparities in incidence and survival for pediatric out-of-hospital cardiac arrest in the United States. Resuscitation 2025 Notes: In Press.

Shaddy R, Gong J, Garito T, Solar-Yohay S, Zhang S, Prescott MF, Bonnet D, Kantor PF, Burch M, Mao C, Cilliers A, Canter C, Law Y, Grutter G, Wang JK, Jeewa A, Rossano J; PANORAMA‐HF investigators.. : Association between NT-proBNP changes and clinical outcomes in paediatric patients with heart failure: Insights from PANORAMA-HF and PARADIGM-HF ESC Heart Failure 2025 Notes: In Press.

Ahluwalia M, Liu J, Olivotto I, Parikh V, Ashley EA, Michels M, Ingles J, Lampert R, Stendahl JC, Colan SD, Abrams D, Pereira AC, Rossano JW, Ryan TD, Owens AT, Ware JS, Saberi S, Helms AS, Day S, Claggett B, Ho CY, Lakdawala NK: Clinical trajectory of NYHA functional class I patients with obstructive hypertrophic cardiomyopathy. JACC Heart Failure. JACC: Heart Failure 13: 332-343, 2025.

Schmitt C, Beasley G, Guerrier K, Kramer J, Naim MY, Griffis H, McNally B, Chan PS, Al-Araji R, Rossano J. : COVID-19 and pediatric out-of-hospital cardiac arrest using U.S. registry database. Resuscitation Plus 22: 100869, 2025.

Ostrominski JW, Claggett BL, Jerosch-Herold M, Raja AA, Day SM, Russell MW, Zahka K, Pereira AC, Colan SD, Murphy AM, Canter C, Bach RG, Wheeler MT, Rossano JW, Owens AT, Mestroni L, Taylor MRG, Patel AR, Wilmot I, Soslow JH, Becker JR, Lakdawala NK, Bundgaard H, Vargas JD, Ho CY; Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Investigators: Valsartan and cardiac remodeling in early-stage hypertrophic cardiomyopathy: the VANISH randomized clinical trial cardiac magnetic resonance substudy. JAMA Cardiology 2025 Notes: In Press.

Greenberg B, Taylor M, Adler E, Colan S, Ricks D, Yarabe P, Battiprolu G, Shah K, Coggins M, Carou-Keenan S, Schwartz JD, Rossano JW: Phase 1 study of AAV9.LAMP2B gene therapy in Danon disease. The New England Journal of Medicine 392: 972-983, 2025.

Wooster L, O’Connor MJ, Zhang X, Mavroudis CD, Maeda K, Ahmed H, Edwards J, Lin KY, Wittlieb-Weber C, Rossano J, Edelson JB: Impact of heart transplant allocation changes on waitlist mortality and clinical practice in pediatric and adult patients with congenital heart disease and cardiomyopathy. Circulation 151: 814-824, 2025.